1. Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development
    Silvia Di Agostino et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  2. TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy
    Shixiang Wang et al, 2024, Journal for ImmunoTherapy of Cancer CrossRef
  3. The clinical and prognostic significance of CMTM6/PD-L1 in oncology
    Mahmoud Mohammad Yaseen et al, 2022, Clinical and Translational Oncology CrossRef
  4. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer
    Chandra Kishore et al, 2022, Molecular and Cellular Biochemistry CrossRef
  5. Emerging Roles of Exosomal Circular RNAs in Cancer
    Takahiro Seimiya et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  6. Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
    Shuai Shi et al, 2022, BioMed Research International CrossRef
  7. The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy
    Zhixiao Fang et al, 2021, Frontiers in Immunology CrossRef
  8. The Emerging Picture of the Roles of CircRNA-CDR1as in Cancer
    Chaohua Jiang et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  9. Circular RNAs Involve in Immunity of Digestive Cancers From Bench to Bedside: A Review
    Chunyue Chen et al, 2022, Frontiers in Immunology CrossRef
  10. The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
    Yu Ma et al, 2024, Cell Death & Disease CrossRef
  11. The role of circRNA in breast cancer drug resistance
    Shaofeng Yang et al, 2024, PeerJ CrossRef
  12. Current advancements in PD-L1 modulation by CMTM6 in malignant tumors
    Lisha Zhang et al, 2024, Oncologie CrossRef
  13. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
    Tong Zhang et al, 2022, Frontiers in Immunology CrossRef
  14. CMTM6, a potential immunotherapy target
    Jie Liang et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
  15. Interplay between programmed death-ligand 1 and non-coding RNAs
    Soudeh Ghafouri-Fard et al, 2022, Frontiers in Immunology CrossRef